Cargando…

Predictive model for acute abdominal pain after transarterial chemoembolization for liver cancer

BACKGROUND: Transarterial chemoembolization (TACE) is the first-line treatment for patients with unresectable liver cancer; however, TACE is associated with postembolization pain. AIM: To analyze the risk factors for acute abdominal pain after TACE and establish a predictive model for postembolizati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bian, Li-Fang, Zhao, Xue-Hong, Gao, Bei-Lei, Zhang, Sheng, Ge, Guo-Mei, Zhan, Dong-Di, Ye, Ting-Ting, Zheng, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Retrospective Cohort Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438199/ https://www.ncbi.nlm.nih.gov/pubmed/32874056 http://dx.doi.org/10.3748/wjg.v26.i30.4442

Ejemplares similares

Radiological response and inflammation scores predict tumour recurrence in patients treated with transarterial chemoembolization before liver transplantation
por: Nicolini, Daniele, et al.
Publicado: (2017)

Effect and safety of sorafenib in patients with intermediate hepatocellular carcinoma who received transarterial chemoembolization: A retrospective comparative study
por: Lei, Xue-Fen, et al.
Publicado: (2018)

Early prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization plus sorafenib
por: Meng, Xiao-Chun, et al.
Publicado: (2018)

Impact of alcohol consumption on treatment outcome of hepatocellular carcinoma patients with viral hepatitis who underwent transarterial chemoembolization
por: Rattanasupar, Attapon, et al.
Publicado: (2022)

Simultaneous transarterial chemoembolization and radiofrequency ablation for large hepatocellular carcinoma
por: Duan, Feng, et al.
Publicado: (2020)

Identification of predictive factors for post-transarterial chemoembolization liver failure in hepatocellular carcinoma patients: A retrospective study
por: Yuan, Min, et al.
Publicado: (2022)

Clinical efficacy of gemcitabine and cisplatin-based transcatheter arterial chemoembolization combined with radiotherapy in hilar cholangiocarcinoma
por: Zheng, Wen-Heng, et al.
Publicado: (2019)

Prognostic factors and predictors of postoperative adjuvant transcatheter arterial chemoembolization benefit in patients with resected hepatocellular carcinoma
por: Chen, Ming-Yu, et al.
Publicado: (2020)

Evaluation of the relationship between hepatocellular carcinoma location and transarterial chemoembolization efficacy
por: Miki, Izumi, et al.
Publicado: (2017)

Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization
por: Ventura, Yossi, et al.
Publicado: (2018)

Idarubicin vs doxorubicin in transarterial chemoembolization of intermediate stage hepatocellular carcinoma
por: Roth, Gaël Stéphane, et al.
Publicado: (2020)

Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase
por: Tan, You-Wen, et al.
Publicado: (2017)

Validation of the six-and-twelve criteria among patients with hepatocellular carcinoma and performance score 1 receiving transarterial chemoembolization
por: Wang, Zhe-Xuan, et al.
Publicado: (2020)

Transarterial chemoembolization using 40 µm drug eluting beads for hepatocellular carcinoma
por: Greco, Giorgio, et al.
Publicado: (2017)

Transarterial chemoembolization combined with radiofrequency ablation in the treatment of large hepatocellular carcinoma with stage C
por: Sun, Sha-Sha, et al.
Publicado: (2022)

Progressive liver injury and increased mortality risk in COVID-19 patients: A retrospective cohort study in China
por: Zhang, Shui-Sheng, et al.
Publicado: (2021)

Expected outcomes and patients’ selection before chemoembolization—“Six-and-Twelve or Pre-TACE-Predict” scores may help clinicians: Real-life French cohorts results
por: Adhoute, Xavier, et al.
Publicado: (2021)

Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma
por: Niu, Xiang-Ke, et al.
Publicado: (2021)

Clinical outcomes of lenvatinib plus transarterial chemoembolization with or without programmed death receptor-1 inhibitors in unresectable hepatocellular carcinoma
por: Wang, Yan-Yu, et al.
Publicado: (2023)

Validation and evaluation of clinical prediction systems for first and repeated transarterial chemoembolization in unresectable hepatocellular carcinoma: A Chinese multicenter retrospective study
por: Wang, Zhe-Xuan, et al.
Publicado: (2020)

Efficacy of intra-arterial contrast-enhanced ultrasonography during transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma
por: Shiozawa, Kazue, et al.
Publicado: (2018)

Hepatic artery infusion with raltitrexed or 5-fluorouracil for colorectal cancer liver metastasis
por: Guo, Jian-Hai, et al.
Publicado: (2017)

Baseline hepatocyte ballooning is a risk factor for adverse events in patients with chronic hepatitis B complicated with nonalcoholic fatty liver disease
por: Tan, You-Wen, et al.
Publicado: (2023)

Clinical characteristics and prognosis of non-small cell lung cancer patients with liver metastasis: A population-based study
por: Wang, Jun-Feng, et al.
Publicado: (2022)

Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma
por: Wang, Ting, et al.
Publicado: (2017)

Efficacy of transcatheter arterial chemoembolization using pirarubicin-loaded microspheres combined with lobaplatin for primary liver cancer
por: Zhang, Chao, et al.
Publicado: (2022)

Evaluation of short-term effects of drug-loaded microspheres and traditional transcatheter arterial chemoembolization in the treatment of advanced liver cancer
por: Ye, Ting, et al.
Publicado: (2022)

Factors associated with surgery in patients with intra-abdominal fistulizing Crohn's disease
por: Yaari, Shaul, et al.
Publicado: (2016)

Acute-on-chronic liver failure in a multi-ethnic Asian city: A comparison of patients identified by Asia-Pacific Association for the Study of the Liver and European Association for the Study of the Liver definitions
por: Selva Rajoo, Anandraj, et al.
Publicado: (2017)

High rate of complete histopathological response in hepatocellular carcinoma patients after combined transarterial chemoembolization and stereotactic body radiation therapy
por: Bauer, Ulrike, et al.
Publicado: (2021)

Pain management in patients with hepatocellular carcinoma after transcatheter arterial chemoembolisation: A retrospective study
por: Guan, Yan, et al.
Publicado: (2023)

Early warning prevention and control strategies to reduce perioperative venous thromboembolism in patients with gastrointestinal cancer
por: Lu, Yun, et al.
Publicado: (2022)

Comparison of clinicopathological characteristics and survival outcomes between gallbladder mucinous adenocarcinoma and gallbladder adenocarcinoma: A propensity score-matched study
por: Yang, Wen-Wei, et al.
Publicado: (2023)

Effect of airplane transport of donor livers on post-liver transplantation survival
por: Huang, Yi, et al.
Publicado: (2016)

Recent trends in liver transplantation for alcoholic liver disease in the United States
por: Kling, Catherine E, et al.
Publicado: (2017)

Clinical value of predictive models based on liver stiffness measurement in predicting liver reserve function of compensated chronic liver disease
por: Lai, Rui-Min, et al.
Publicado: (2022)

Establishment of a risk assessment score for deep vein thrombosis after artificial liver support system treatment
por: Ye, Yun, et al.
Publicado: (2021)

Angiotensin converting enzymes inhibitors or angiotensin receptor blockers should be continued in COVID-19 patients with hypertension
por: Tian, Ci, et al.
Publicado: (2021)

Prognostic factors of survival and a new scoring system for liver resection of colorectal liver metastasis
por: Cheng, Kai-Chi, et al.
Publicado: (2022)

Cardiac risk factors limiting survival to liver transplantation in patients with nonalcoholic fatty liver disease
por: Delicce, Michael, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_frh3o51nb6msgopeg1h8qk0ud1